Evidence for morphological alterations in prefrontal white matter glia in schizophrenia and bipolar disorder

Journal of Psychiatry and Neuroscience

Volumn 39, Issue 6, 2014, Pages 376-385

  Hercher, Christa ^a   Chopra, Vikramjit ^a   Beasley, Clare L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2', 3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; ALLOGRAFT INFLAMMATORY FACTOR 1; GLIAL FIBRILLARY ACIDIC PROTEIN; MYELIN BASIC PROTEIN; UNCLASSIFIED DRUG; 2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; AIF1 PROTEIN, HUMAN; DNA BINDING PROTEIN;

ADULT; ARTICLE; ASTROCYTE; BIPOLAR DISORDER; CAUSE OF DEATH; CELL DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; MICROSCOPY; MORPHOLOGICAL TRAIT; OLIGODENDROGLIA; PREFRONTAL CORTEX; PREFRONTAL WHITE MATTER GLIA; SCHIZOPHRENIA; SUBSTANCE USE; SUICIDE; WHITE MATTER; COMPARATIVE STUDY; GLIA; METABOLISM; MICROPHOTOGRAPHY; MIDDLE AGED; PATHOLOGY;

2',3'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; ADULT; BIPOLAR DISORDER; DNA-BINDING PROTEINS; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEUROGLIA; PHOTOMICROGRAPHY; PREFRONTAL CORTEX; SCHIZOPHRENIA; WHITE MATTER;

EID: 84908263148     PISSN: 11804882     EISSN: 14882434     Source Type: Journal    
DOI: 10.1503/jpn.130277     Document Type: Article

References (59)

1. World Health Organization (WHO). Global burden of disease. Available: http:///www.who.int/healthinfo/global_burden_disease/ GBD_report_2004update_full.pdf (accessed 2013 Jan. 23).
2. Mahon K, Burdick KE, Szeszko PR. A role for white matter abnormalities in the pathophysiology of bipolar disorder. Neurosci Biobehav Rev 2010;34:533-54.
3. Walterfang M, Wood SJ, Velakoulis D, et al. Neuropathological, neurogenetic and neuroimaging evidence for white matter pathology in schizophrenia. Neurosci Biobehav Rev 2006;30:918-48.
4. Ellison-Wright I, Bullmore E. Meta-analysis of diffusion tensor imaging studies in schizophrenia. Schizophr Res 2009;108:3-10.
5. Nortje G, Stein DJ, Radua J, et al. Systematic review and voxel-based meta-analysis of diffusion tensor imaging studies in bipolar disorder. J Affect Disord 2013;150:192-200.
6. Arnone D, McIntosh AM, Tan GM, et al. Meta-analysis of magnetic resonance imaging studies of the corpus callosum in schizophrenia. Schizophr Res 2008;101:124-32.
7. Kempton MJ, Geddes JR, Ettinger U, et al. Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder. Arch Gen Psychiatry 2008;65:1017-32.
8. Beasley CL, Honavar M, Everall IP, et al. Two-dimensional assessment of cytoarchitecture in the superior temporal white matter in schizophrenia, major depressive disorder and bipolar disorder. Schizophr Res 2009;115:156-62.
9. Hof PR, Haroutunian V, Friedrich VL Jr, et al. Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol Psychiatry 2003;53:1075-85.
10. Barley K, Dracheva S, Byne W. Subcortical oligodendrocyte-and astrocyte-associated gene expression in subjects with schizophrenia, major depression and bipolar disorder. Schizophr Res 2009;112:54-64.
11. McCullumsmith RE, Gupta D, Beneyto M, et al. Expression of transcripts for myelination-related genes in the anterior cingulate cortex in schizophrenia. Schizophr Res 2007;90:15-27.
12. Segal D, Schmitz C, Hof PR. Spatial distribution and density of oligodendrocytes in the cingulum bundle are unaltered in schizophrenia. Acta Neuropathol 2009;117:385-94.
13. Mosebach J, Keilhoff G, Gos T, et al. Increased nuclear Olig1-expression in the pregenual anterior cingulate white matter of patients with major depression: A regenerative attempt to compensate oligodendrocyte loss? J Psychiatr Res 2013;47:1069-79.
14. Uranova NA, Vostrikov VM, Orlovskaya DD, et al. Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr Res 2004;67:269-75.
15. Williams MR, Hampton T, Pearce RK, et al. Astrocyte decrease in the subgenual cingulate and callosal genu in schizophrenia. Eur Arch Psychiatry Clin Neurosci 2013;263:41-52.
16. Beasley CL, Dwork AJ, Rosoklija G, et al. Metabolic abnormalities in fronto-striatal-thalamic white matter tracts in schizophrenia. Schizophr Res 2009;109:159-66.
17. Mitkus SN, Hyde TM, Vakkalanka R, et al. Expression of oligodendrocyte-associated genes in dorsolateral prefrontal cortex of patients with schizophrenia. Schizophr Res 2008;98:129-38.
18. Fillman SG, Cloonan N, Catts VS, et al. Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia. Mol Psychiatry 2013;18:206-14.
19. Torrey EF, Webster M, Knable M, et al. The stanley foundation brain collection and neuropathology consortium. Schizophr Res 2000;44:151-5.
20. Wolswijk G. Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis. Brain 2000;123:105-15.
21. Chana G, Landau S, Beasley C, et al. Two-dimensional assessment of cytoarchitecture in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia: evidence for decreased neuronal somal size and increased neuronal density. Biol Psychiatry 2003;53:1086-98.
22. Abercrombie M. Estimation of nuclear population from microtome sections. Anat Rec 1946;94:239-47.
23. Schmitz C. Variation of fractionator estimates and its prediction. Anat Embryol (Berl) 1998;198:371-97.
24. Duyckaerts C, Godefroy G. Voronoi tessellation to study the numerical density and the spatial distribution of neurones. J Chem Neuroanat 2000;20:83-92.
25. Duyckaerts C, Godefroy G, Hauw JJ. Evaluation of neuronal numerical density by Dirichlet tessellation. J Neurosci Methods 1994;51:47-69.
26. Beasley CL, Honer WG, Bergmann K, et al. Reductions in cholesterol and synaptic markers in association cortex in mood disorders. Bipolar Disord 2005;7:449-55.
27. Feresten AH, Barakauskas V, Ypsilanti A, et al. Increased expression of glial fibrillary acidic protein in prefrontal cortex in psychotic illness. Schizophr Res 2013;150:252-7.
28. Byne W, Dracheva S, Chin B, et al. Schizophrenia and sex associated differences in the expression of neuronal and oligodendrocyte-specific genes in individual thalamic nuclei. Schizophr Res 2008;98:118-28.
29. Mackay CE, Roddick E, Barrick TR, et al. Sex dependence of brain size and shape in bipolar disorder: an exploratory study. Bipolar Disord 2010;12:306-11.
30. Hedreen JC. What was wrong with the Abercrombie and empirical cell counting methods? A review. Anat Rec 1998;250:373-80.
31. Mann JJ, Currier DM. Stress, genetics and epigenetic effects on the neurobiology of suicidal behavior and depression. Eur Psychiatry 2010;25:268-71.
32. Turecki G, Ernst C, Jollant F, et al. The neurodevelopmental origins of suicidal behavior. Trends Neurosci 2012;35:14-23.
33. th ed. Waltham (MA): Academic Press; 2005:51-73.
34. Katsel P, Davis KL, Li C, et al. Abnormal indices of cell cycle activity in schizophrenia and their potential association with oligodendrocytes. Neuropsychopharmacology 2008;33:2993-3009.
35. Andreazza AC, Wang JF, Salmasi F, et al. Specific subcellular changes in oxidative stress in prefrontal cortex from patients with bipolar disorder. J Neurochem 2013;127:552-61.
36. McTigue DM, Tripathi RB. The life, death, and replacement of oligodendrocytes in the adult CNS. J Neurochem 2008;107:1-19.
37. Franklin RJ, Ffrench-Constant C. Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci 2008;9:839-55.
38. Benedetti F, Bollettini I, Barberi I, et al. Lithium and GSK3-β promoter gene variants influence white matter microstructure in bipolar disorder. Neuropsychopharmacology 2013;38:313-27.
39. De Sarno P, Axtell RC, Raman C, et al. Lithium prevents and ameliorates experimental autoimmune encephalomyelitis. J Immunol 2008;181:338-45.
40. Orre K, Wennström M, Tingström A. Chronic lithium treatment decreases NG2 cell proliferation in rat dentate hilus, amygdala and corpus callosum. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:503-10.
41. McQuillin A, Rizig M, Gurling HM. A microarray gene expression study of the molecular pharmacology of lithium carbonate on mouse brain mRNA to understand the neurobiology of mood stabilization and treatment of bipolar affective disorder. Pharmacogenet Genomics 2007;17:605-17.
42. Harper C. The neuropathology of alcohol-specific brain damage, or does alcohol damage the brain? J Neuropathol Exp Neurol 1998;57:101-10.
43. Liu J, Lewohl JM, Harris RA, et al. Patterns of gene expression in the frontal cortex discriminate alcoholic from nonalcoholic individuals. Neuropsychopharmacology 2006;31:1574-82.
44. Albertson DN, Pruetz B, Schmidt CJ, et al. Gene expression profile of the nucleus accumbens of human cocaine abusers: evidence for dysregulation of myelin. J Neurochem 2004;88:1211-9.
45. Falkai P, Honer WG, David S, et al. No evidence for astrogliosis in brains of schizophrenic patients. A post-mortem study. Neuropathol Appl Neurobiol 1999;25:48-53.
46. Rajkowska G, Miguel-Hidalgo JJ, Makkos Z, et al. Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia. Schizophr Res 2002;57:127-38.
47. Oberheim NA, Takano T, Han X, et al. Uniquely hominid features of adult human astrocytes. J Neurosci 2009;29:3276-87.
48. Foster R, Kandanearatchi A, Beasley C, et al. Calprotectin in microglia from frontal cortex is up-regulated in schizophrenia: Evidence for an inflammatory process? Eur J Neurosci 2006;24:3561-6.
49. Steiner J, Mawrin C, Ziegeler A, et al. Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization. Acta Neuropathol 2006;112:305-16.
50. Molofksy AV, Krencik R, Ullian EM, et al. Astrocytes and disease: a neurodevelopmental perspective. Genes Dev 2012;26:891-907.
51. Bernstein HG, Smalla KH, Dürrschmidt D, et al. Increased density of prohibitin-immunoreactive oligodendrocytes in the dorsolateral prefrontal white matter of subjects with schizophrenia suggests extraneuronal roles for the protein in the disease. Neuromolecular Med 2012;14:270-80.
52. Farkas N, Lendeckel U, Dobrowolny H, et al. Reduced density of ADAM 12-immunoreactive oligodendrocytes in the anterior cingulate white matter of patients with schizophrenia. World J Biol Psychiatry 2010;11:556-66.
53. Bernstein HG, Keilhoff G, Bukowska A, et al. ADAM (a disintegrin and metalloprotease) 12 is expressed in rat and human brain and localized to oligodendrocytes. J Neurosci Res 2004;75:353-60.
54. Benes FM, Lange N. Two-dimensional versus three-dimensional cell counting: a practical perspective. Trends Neurosci 2001;24:11-7.
55. Niu J, Mei F, Li N, et al. Haloperidol promotes proliferation but inhibits differentiation in rat oligodendrocyte progenitor cell cultures. Biochem Cell Biol 2010;88:611-20.
56. Selemon LD, Lidow MS, Goldman-Rakic PS. Increased volume and glial density in primate prefrontal cortex associated with chronic antipsychotic drug exposure. Biol Psychiatry 1999;46:161-72.
57. Steiner J, Sarnyai Z, Westphal S, et al. Protective effects of haloperidol and clozapine on energy-deprived OLN-93 oligodendrocytes. Eur Arch Psychiatry Clin Neurosci 2011;261:477-82.
58. Wang H, Xu H, Niu J, et al. Haloperidol activates quiescent oligodendroglia precursor cells in the adult mouse brain. Schizophr Res 2010;119:164-74.
59. Konopaske GT, Dorph-Petersen KA, Sweet RA, et al. Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys. Biol Psychiatry 2008;63:759-65.